The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and FDA Peptide Transparency Scandal 2026: Who's Really Controlling BPC 157, TB 500 & More? YouTube FDA to review broader access to restricted peptides in July FDA's Overreach on Compounded Peptides Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with